Search research articles
Contact Us
Filters
Showing results (651-660 of 662) with videos related to
Page
of 67
Sort By:
Bing Du Xue Bao = Chinese Journal of Virology
|
April 6, 2010
[Establishment of a method for rapid detection of the nucleic acid of the novel A (H1N1) influenza virus]
Da-Yan Wang, Rong-Bao Gao, Xiao-Dan Li, et al.
Nature Medicine
|
November 5, 2021
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Binghe Xu, Qingyuan Zhang, Pin Zhang, et al.
Acta Pharmaceutica Sinica. B
|
May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
Binghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2023
Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression
Fengguang Ma, Yuxiao Liu, Zhimin Hu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 29, 2011
[A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Xi Yan, Li Ren, et al.
Science Advances
|
July 25, 2025
DNA damage response pathway regulates Nrf2 in response to oxidative stress
Xiao-You Jiang, Qi-Qiang Guo, Shan-Shan Wang, et al.
The Lancet. Oncology
|
May 14, 2023
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Pin Zhang, Qingyuan Zhang, Zhongsheng Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 30, 2025
Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway
Qi-Qiang Guo, Shan-Shan Wang, Xiao-You Jiang, et al.
Bing Du Xue Bao = Chinese Journal of Virology
|
April 6, 2010
[Laboratory confirmation of the first influenza A (H1N1) imported case in Mainland China]
Wei Wang, Ming Pan, Guo-Hui Chang, et al.
Current Vascular Pharmacology
|
November 1, 2014
Dynamic Changes in Phenotypic Groups in Patients with Stable Angina Pectoris after Treatment with Xinxuekang Capsule: A Randomized Controlled Trial
Li-Ying Wang, Jian-Yuan Tang, Jun Liu, et al.
Page
of 67
Search research articles
Search
Showing results (651-660 of 662) with videos related to
Sort By:
Page
of 67
Bing Du Xue Bao = Chinese Journal of Virology
|
April 6, 2010
[Establishment of a method for rapid detection of the nucleic acid of the novel A (H1N1) influenza virus]
Da-Yan Wang, Rong-Bao Gao, Xiao-Dan Li, et al.
Nature Medicine
|
November 5, 2021
Dalpiciclib or placebo plus fulvestrant in hormone receptor-positive and HER2-negative advanced breast cancer: a randomized, phase 3 trial
Binghe Xu, Qingyuan Zhang, Pin Zhang, et al.
Acta Pharmaceutica Sinica. B
|
May 30, 2023
Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial
Binghe Xu, Qingyuan Zhang, Xichun Hu, et al.
Hepatology (Baltimore, Md.)
|
January 21, 2023
Intrahepatic osteopontin signaling by CREBZF defines a checkpoint for steatosis-to-NASH progression
Fengguang Ma, Yuxiao Liu, Zhimin Hu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer
|
January 29, 2011
[A multicenter randomized phase III trial of domestic product of rmhTNF in the treatment of non-small cell lung cancer]
Qinghua Zhou, Xi Yan, Li Ren, et al.
Science Advances
|
July 25, 2025
DNA damage response pathway regulates Nrf2 in response to oxidative stress
Xiao-You Jiang, Qi-Qiang Guo, Shan-Shan Wang, et al.
The Lancet. Oncology
|
May 14, 2023
Dalpiciclib plus letrozole or anastrozole versus placebo plus letrozole or anastrozole as first-line treatment in patients with hormone receptor-positive, HER2-negative advanced breast cancer (DAWNA-2): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Pin Zhang, Qingyuan Zhang, Zhongsheng Tong, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 30, 2025
Mitochondrial ROS triggers mitophagy through activating the DNA damage response signaling pathway
Qi-Qiang Guo, Shan-Shan Wang, Xiao-You Jiang, et al.
Bing Du Xue Bao = Chinese Journal of Virology
|
April 6, 2010
[Laboratory confirmation of the first influenza A (H1N1) imported case in Mainland China]
Wei Wang, Ming Pan, Guo-Hui Chang, et al.
Current Vascular Pharmacology
|
November 1, 2014
Dynamic Changes in Phenotypic Groups in Patients with Stable Angina Pectoris after Treatment with Xinxuekang Capsule: A Randomized Controlled Trial
Li-Ying Wang, Jian-Yuan Tang, Jun Liu, et al.
Page
of 67